Grants Search Results

Dr. Shlien is working to define the key molecular landmarks of aggressive childhood cancers. Understanding how these lethal tumors arise will lead to better treatment and surveillance. This will impact the management of these young patients, and improve the precision of cancer care. The St. Baldrick's Robert J. Arceci Innovation Award is given in honor of the late Dr. Robert Arceci. A pioneer in the field, this award reflects Dr. Arceci's values including creativity, collaboration, and commitment to early- to mid-career scientists.

This grant funds a medical school student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty. This year it is estimated that 800 children will be diagnosed with osteosarcoma (bone cancer). It is thought that sex hormones play a role in the onset of the disease, as more boys than girls get osteosarcoma and the cancer develops at the time of puberty. We hypothesize that a key molecule in estrogen signaling, that is crucial for normal bone, is turned off in osteosarcomas, preventing those cells from being normal bone. The student is helping to understand the molecular mechanisms of estrogen silencing in osteosarcomas.

This grant funds a medical school student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty. Pilocytic astrocytoma is the most common brain tumor that occurs in children. Though it only rarely does so, when this tumor spreads, it becomes much more difficult to treat. This student is working to understand why these tumors spread.

Through this partnership with The Kids' Cancer Project, proceeds from St. Baldrick's events in Australia fund life-saving research in Australia.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a immunotherapy focused Clinical Research Associate to ensure that more kids can be treated on immunotherapy clinical trials, often their best hope for a cure.

Young adulthood is a time filled with exciting possibilities and also difficult challenges. People at this stage of life may be deciding on or attending school, selecting a career or working hard at their jobs, dating or in a relationship, and may be planning for or raising children. A cancer diagnosis does not fit into these plans and goals. Researchers are finding that the biology of the cancers in people of this age group are different, and increasing data indicates that adult patients with some cancers would benefit by being treated on what are traditionally pediatric therapies. Ochsner's Adolescent and Young Adult (AYA) Cancer and Survivor program is the first and only one of its kind in the region. The team is made up of professionals from pediatric and adult medicine. This program is designed for people between the ages of 15 and 39 years of age with cancer -newly diagnosed, actively in therapy and or cancer survivors. This grant supports a Nurse Coordinator who works with new patients in the combined AYA Cancer and Survivor Clinic, to ensure they have access to the best clinical trials for their cancer.

People between the ages of 15 to 40 years old with cancer have a lot of challenges like having to juggle their cancer diagnoses with their day to day lives - school, a job or family, and even things like going out with friends or keeping up with exercise or hobbies. They can feel isolated, afraid and unaware of new drugs that can help, or could be far away from hospitals that offers treatment through clinical trials. This grant supports an adolescent and young adult patient navigator to help young people address these issues throughout their treatment, get them the help they need and steer them towards newer treatments through trials that may increase their chance of a cure from cancer.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

The Jim Brady's St. Baldrick's grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure. This grant is named in honor of the 20th annual head-shaving event at Jim Brady's and to celebrate its many volunteers over the years who have supported the event at the birthplace of St. Baldrick's.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a nurse navigator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Adolescent and Young Adult (AYA) patients with cancer form a unique group, different than both little children and older adults with cancer. Historically the AYA cancer population has delayed access to care, delay in diagnosis, inconsistent treatment and follow-up, and decreased participation in clinical trials, often leading to inferior survival and quality of life compared to either younger children or older adults. Stony Brook Cancer Center recently started a formal AYA cancer program, with the goal of providing enhanced care and research for AYA patients. This grant supports a nurse navigator for the AYA program, to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Adolescent and young adults with cancer (AYAs) represent a unique group of patients that do not do as well on treatment when compared to younger children and older adults. There are many reasons why AYAs do not do as well, which include the specific types of cancers that affect this age group, poor participation in clinical trials, psychosocial challenges of being a teenager with a cancer diagnosis, and the location of cancer treatment. This grant supports the development of an AYA program that will help meet the specific needs of this patient population, with a focus on increased access to clinical trials, to improve overall outcomes.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.